VRDN

Viridian Therapeutics Inc

NASDAQ · Biotechnology

$29.25

+0.08 (+0.27%)

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

Analyst Consensus

Strong Buy

24 analysts

Buy 21 88%

Hold 3 13%

Sell 0 0%

Price Target

Analyst Price Target +118.3% upside

Low Target $43.31

Average Target $63.84

High Target $68.31

Current Price $29.25

Current
$29.25

Target
$63.84

$43.31 $63.84 avg $68.31